Learning Objectives:
- Discuss current treatment outcomes in advanced-phase MPNs
- Review incidence of IDH mutations in pH-negative advanced-phase MPNs
- Discuss potential treatment strategies in IDH-mutated advanced-phase MPNs
and
- Review the unique challenges in the care of the AYA patient with cancer
- Discuss the spectrum of symptoms experienced by AYA patients and identify gaps in the literature
- Describe a study to determine the impact of early palliative care involvement on AYA patients with hematologic malignancies
Session date:
11/04/2019 - 12:00pm to 1:00pm CST
Location:
UCMC
900 East 57th Street
KCBD Auditorium 1103
Chicago, IL
60637
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Anand A. Patel, MD and Amy Y. Wang, MD, PhD